4.5 Review

Neuroplasticity in Alzheimer's disease

Journal

JOURNAL OF NEUROSCIENCE RESEARCH
Volume 70, Issue 3, Pages 402-437

Publisher

WILEY
DOI: 10.1002/jnr.10441

Keywords

neuroplasticity; Alzheimer's; genetics; apo-lipoprotein E; therapeutics; pharmacogenetics

Categories

Ask authors/readers for more resources

Ramon y Cajal proclaimed in 1928 that once development was ended, the founts of growth and regeneration of the axons and dendrites dried up irrevocably. In the adult centers the nerve paths are something fixed, ended and immutable. Everything must die, nothing may be regenerated. It is for the science of the future to change, if possible, this harsh decree. (Ramon y Cajal, 1928). In large part, despite the extensive knowledge gained since then, the latter directive has not yet been achieved by 'modern' science. Although we know now that Ramon y Cajal's observation on CNS plasticity is largely true (for lower brain and primary cortical structures), there are mechanisms for recovery from CNS injury. These mechanisms, however, may contribute to the vulnerability to neurodegenerative disease. They may also be exploited therapeutically to help alleviate the suffering from neurodegenerative conditions. Published 2002 Wiley-Liss, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available